Eric McDade Selected Research

type 3 familial Alzheimer disease

1/2018

Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric McDade Research Topics

Disease

39	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 12/2011
16	Cognitive Dysfunction 02/2022 - 08/2012
9	Dementia (Dementias) 02/2022 - 12/2011
8	Disease Progression 04/2022 - 01/2018
8	Atrophy 01/2022 - 08/2012
3	Cerebral Cortical Thinning 01/2020 - 11/2013
3	Amyloidosis 10/2018 - 09/2015
2	Inflammation (Inflammations) 04/2022 - 09/2021
2	Stroke (Strokes) 01/2015 - 09/2013
1	Tauopathies 02/2022
1	Neuroinflammatory Diseases 02/2022
1	Synucleinopathies 02/2022
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2021
1	Hypoxia (Hypoxemia) 09/2021
1	Virus Diseases (Viral Diseases) 09/2021
1	Amyloid Plaque 07/2021
1	Edema (Dropsy) 07/2021
1	Asymptomatic Diseases 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	type 3 familial Alzheimer disease 01/2018
1	Down Syndrome (Down's Syndrome) 01/2018
1	Infections 07/2016
1	Heart Diseases (Heart Disease) 09/2013
1	Diabetes Mellitus 09/2013
1	Psychotic Disorders (Schizoaffective Disorder) 09/2013
1	Hypertension (High Blood Pressure) 09/2013
1	Fabry Disease (Fabry's Disease) 01/2010
1	Parkinson Disease (Parkinson's Disease) 01/2008
1	Dyskinesias (Dyskinesia) 01/2008
1	Dystonia (Limb Dystonia) 01/2008

Drug/Important Bio-Agent (IBA)

34	Amyloid (Amyloid Fibrils)IBA 10/2022 - 08/2012
25	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2011
6	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2021 - 04/2013
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 10/2016
2	Amyloid beta-PeptidesIBA 02/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2018
2	tau Proteins (tau Protein)IBA 01/2020 - 08/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 11/2013
2	Apolipoproteins E (ApoE)IBA 09/2015 - 01/2015
1	Peptides (Polypeptides)IBA 02/2022
1	Circular RNAIBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2021
1	LipidsIBA 09/2021
1	MineralsIBA 09/2021
1	NF-kappa B (NF-kB)IBA 09/2021
1	solanezumabIBA 07/2021
1	gantenerumabIBA 07/2021
1	Biological ProductsIBA 07/2021
1	Immunoglobulin G (IgG)IBA 07/2016
1	Indicators and Reagents (Reagents)IBA 09/2015
1	flutemetamolIBA 01/2015
1	Deoxyglucose (2 Deoxy D glucose)IBA 11/2013
1	Antipsychotic Agents (Antipsychotics)IBA 09/2013
1	GlycosphingolipidsIBA 01/2010
1	alpha-Galactosidase (Beano)IBA 01/2010
1	Pharmaceutical PreparationsIBA 01/2008

Therapy/Procedure

3	Therapeutics 02/2022 - 12/2019
1	Secondary Prevention 01/2020
1	Home Nursing (Nursing, Home) 09/2013
1	Institutionalization (Institutionalized Persons) 09/2013